Zydus Lifesciences (ZYDUSLIFE) — Financial Results

1 Financial Results 🔴 High Importance Neutral 📄 PDF

Zydus Lifesciences reported Q3 FY2026 total income of ₹68,645 million with net profit of ₹10,421 million from continuing operations. Nine-month FY2026 revenue reached ₹195,614 million and net profit ₹37,675 million. Earnings per share for nine months stood at ₹37.44. The company filed unaudited financial results for the quarter and nine months ended December 31, 2025.

2 Financial Results 🔴 High Importance Neutral 📄 PDF

Zydus Lifesciences Limited disclosed the availability of an audio recording from its investor call discussing unaudited financial results for the quarter and nine-month period ended December 31, 2025. The company filed this disclosure under SEBI Listing Regulations 30 and 46(2)(oa) to ensure investor transparency. The audio recording has been made available on the company's website for stakeholder access.

📊 Stock Analysis — ZYDUSLIFE ✨ Ask AI About This

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,01,800.69 Cr P/E: 22.5

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

💡 Ask AI about this filing

"How does this financial results affect Zydus Lifesciences Limited's outlook?" "What did Zydus Lifesciences Limited announce on 10 February 2026?" "Is this positive or negative for ZYDUSLIFE?"

Ask AI Free →

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

🔥 Also filed on 10 February 2026

APOLLOHOSP Apollo Hospitals Enterprise Limited Financial Results VBL Varun Beverages Limited Financial Results APOLLOHOSP Apollo Hospitals Enterprise Limited Financial Results APOLLOHOSP Apollo Hospitals Enterprise Limited Financial Results APOLLOHOSP Apollo Hospitals Enterprise Limited Corporate Action AXISBANK Axis Bank Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.